Stage FocusPre-Seed, Seed, Series A
GeographyEurope, US, China
TypeCVC
Last Activity2025
Industry Focus
Industries
BiotechMedtechAI
Technical BenchStrong
Investor TypeCVC
ExposureMostly DeepTech Investments
Bio
The Boehringer Ingelheim Venture Fund was established in 2010 as an evergreen CVC, growing from an initial €100M allocation to €350M (roughly $400M). The fund has made 70+ investments including fund-in-fund positions, with 40+ currently in the portfolio.
Focus areas include immuno-oncology, regenerative medicine, infectious diseases, and digital health. Check sizes run €500K to €15M with a 5-7 ye...
Similar Funds
Flagship Pioneering
Cambridge, United States
Pure DeepTechBiotechAgritechAIPre-SeedSeed
Nordic Science Investments
Helsinki, Finland
DeepTech NativeBiotechMedtechAIPre-SeedSeed
Amino Collective
Berlin, Germany
DeepTech NativeBiotechSynthetic BiologyMedtechPre-SeedSeed
Beyond Next Ventures
Tokyo, Japan
Pure DeepTechBiotechMedtechAIPre-SeedSeed
Caixa Capital Risc
Barcelona, Spain
GeneralistBiotechAIMedtechSeedSeries A
Longwood Fund
Boston, United States
Pure DeepTechBiotechMedtechPre-SeedSeed